Li et al. firstly reported that ZFHX4-AS1 was distinctly overexpressed in breast cancer and its silence suppressed the proliferation, invasion, and migration, while promoted cell apoptosis by the use of suppressing the Hippo signaling pathway. Here, ZFHX4 is linked to breast carcinoma.